Skip to main content

Management of fluid intake in patients with overactive bladder

Abstract

Overactive bladder (OAB) syndrome is a prevalent condition that affects millions of people worldwide. There is no curative treatment, and management is aimed at reducing symptoms and improving quality of life. Conservative treatment is first-line therapy for OAB sufferers, including lifestyle interventions, bladder training, and pelvic floor exercises. The evidence for lifestyle interventions in the form of fluid manipulation, weight reduction, and smoking cessation is limited. However, these interventions are cheap and simple and have health benefits. Until recently, the advice regarding fluid manipulation, in terms of volume and type, has been controversial. Increasing evidence suggests that reducing fluid intake can improve OAB symptoms, with a general consensus that caffeine reduction may be beneficial. Further clinical trials are needed on fluid manipulation in terms of the types of fluids drank, the timing of fluid intake, and the effects of exercise and outside ambient temperature on OAB symptoms.

This is a preview of subscription content, access via your institution.

References and Recommended Reading

  1. Abrams P, Cardozo L, Fall M, et al.: The standardisation of terminology of lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Neurourol Urodyn 2002, 21:167–178.

    Article  PubMed  Google Scholar 

  2. Abrams P, Artibani W, Cardozo L, et al.: Reviewing the ICS 2002 terminology report: the ongoing debate. Neurourol Urodyn 2006, 25:293.

    Article  Google Scholar 

  3. Bates CP, Whiteside CG, Turner-Warwick R: Synchronous cine-pressure-flow-cysto-urethrography with special reference to stress and urge incontinence. Br J Urol 1970, 42:714–723.

    Article  CAS  PubMed  Google Scholar 

  4. Hashim H, Abrams P: Is the bladder a reliable witness for predicting detrusor overactivity? J Urol 2006, 175:191–194.

    Article  CAS  PubMed  Google Scholar 

  5. Irwin DE, Milsom I, Hunskaar S, et al.: Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol 2006, 50:1306–1314.

    Article  PubMed  Google Scholar 

  6. Kelleher CJ, Reese PR, Pleil AM, Okano GJ: Health-related quality of life of patients receiving extended-release tolterodine for overactive bladder. Am J Manag Care 2002, 8(Suppl 19):S608–S615.

    PubMed  Google Scholar 

  7. Liberman JN, Hunt TL, Stewart WF, et al.: Health-related quality of life among adults with symptoms of overactive bladder: results from a U.S. community-based survey. Urology 2001, 57:1044–1050.

    Article  CAS  PubMed  Google Scholar 

  8. Komaroff AL, Fagioli LR, Doolittle TH, et al.: Health status in patients with chronic fatigue syndrome and in general population and disease comparison groups. Am J Med 1996, 101:281–290.

    Article  CAS  PubMed  Google Scholar 

  9. Asplund R: Hip fractures, nocturia, and nocturnal polyuria in the elderly. Arch Gerontol Geriatr 2006, 43:319–326.

    Article  CAS  PubMed  Google Scholar 

  10. Brown JS, McGhan WF, Chokroverty S: Comorbidities associated with overactive bladder. Am J Manag Care 2000, 6(Suppl 11):S574–S579.

    CAS  PubMed  Google Scholar 

  11. Reeves P, Irwin D, Kelleher C, et al.: The current and future burden and cost of overactive bladder in five European countries. Eur Urol 2006, 50:1050–1057.

    Article  PubMed  Google Scholar 

  12. Hu TW, Wagner TH, Bentkover JD, et al.: Estimated economic costs of overactive bladder in the United States. Urology 2003, 61:1123–1128.

    Article  PubMed  Google Scholar 

  13. Hu TW, Wagner TH, Bentkover JD, et al.: Costs of urinary incontinence and overactive bladder in the United States: a comparative study. Urology 2004, 63:461–465.

    Article  PubMed  Google Scholar 

  14. Abrams P, Andersson KE, Brubaker L, et al.: Recommendations of the International Scientific Committee: evaluation and treatment of urinary incontinence, pelvic organ prolapse and faecal incontinence. In Incontinence. Edited by Abrams P, Cardozo L, Khoury S, Wein A. Paris: Health Publication Ltd.; 2005:1589–1630.

    Google Scholar 

  15. Dallosso HM, McGrother CW, Matthews RJ, Donaldson MM: The association of diet and other lifestyle factors with overactive bladder and stress incontinence: a longitudinal study in women. BJU Int 2003, 92:69–77.

    Article  CAS  PubMed  Google Scholar 

  16. Bulmer P, Yang Q, Abrams P: Does cigarette smoking cause detrusor instability in women? J Obstet Gynaecol 2001, 21:528–529.

    Article  CAS  PubMed  Google Scholar 

  17. Dowd TT, Campbell JM, Jones JA: Fluid intake and urinary incontinence in older community-dwelling women. J Community Health Nurs 1996, 13:179–186.

    Article  CAS  PubMed  Google Scholar 

  18. Tomlinson BU, Dougherty MC, Pendergast JF, et al.: Dietary caffeine, fluid intake and urinary incontinence in older rural women. Int Urogynecol J Pelvic Floor Dysfunct 1999, 10:22–28.

    Article  CAS  PubMed  Google Scholar 

  19. Griffiths DJ, McCracken PN, Harrison GM, Gormley EA: Relationship of fluid intake to voluntary micturition and urinary incontinence in geriatric patients. Neurourol Urodyn 1993, 12:1–7.

    Article  CAS  PubMed  Google Scholar 

  20. Wyman JF, Elswick RK, Wilson MS, Fantl JA: Relationship of fluid intake to voluntary micturitions and urinary incontinence in women. Neurourol Urodyn 1991, 10:463–473.

    Article  Google Scholar 

  21. Swithinbank L, Hashim H, Abrams P: The effect of fluid intake on urinary symptoms in women. J Urol 2005, 174:187–189.

    Article  CAS  PubMed  Google Scholar 

  22. Hashim H, Abrams P: How should patients with an overactive bladder manipulate their fluid intake? BJU Int 2008, 102:62–66.

    Article  PubMed  Google Scholar 

  23. Hay Smith J, Berghmans B, Burgio K, et al.: Adult conservative management. In Incontinence. Edited by Abrams P, Cardozo L, Khoury S, Wein A. Paris: Health Publication Ltd.; 2009:1025–1120.

    Google Scholar 

  24. Creighton SM, Stanton SL: Caffeine: does it affect your bladder? Br J Urol 1990, 66:613–614.

    Article  CAS  PubMed  Google Scholar 

  25. Bryant CM, Dowell CJ, Fairbrother G: Caffeine reduction education to improve urinary symptoms. Br J Nurs 2002, 11:560–565.

    PubMed  Google Scholar 

  26. Arya LA, Myers DL, Jackson ND: Dietary caffeine intake and the risk for detrusor instability: a case-control study. Obstet Gynecol 2000, 96:85–89.

    Article  CAS  PubMed  Google Scholar 

  27. Hannestad YS, Rortveit G, Daltveit AK, Hunskaar S: Are smoking and other lifestyle factors associated with female urinary incontinence? The Norwegian EPINCONT Study. BJOG 2003, 110:247–254.

    Article  PubMed  Google Scholar 

  28. Brown JS, Seeley DG, Fong J, et al.: Urinary incontinence in older women: who is at risk? Study of Osteoporotic Fractures Research Group. Obstet Gynecol 1996, 87(5 Pt 1):715–721.

    Article  CAS  PubMed  Google Scholar 

  29. Roe B, Doll H: Lifestyle factors and continence status: comparison of self-report data from a postal survey in England. J Wound Ostomy Continence Nurs 1999, 26:312–319.

    CAS  PubMed  Google Scholar 

  30. Dallosso HM, Matthews RJ, McGrother CW, et al.: The association of diet and other lifestyle factors with the onset of overactive bladder: a longitudinal study in men. Public Health Nutr 2004, 7:885–891.

    Article  PubMed  Google Scholar 

  31. Cartwright R, Srikrishna S, Cardozo L, Gonzalez J: Does Diet Coke cause overactive bladder? A 4-way crossover trial, investigating the effect of carbonated soft drinks on overactive bladder symptoms in normal volunteers [abstract 19]. Neurourol Urodyn 2007, 26:626–627.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hashim Hashim.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Hashim, H., Mousa, R.A. Management of fluid intake in patients with overactive bladder. Curr Urol Rep 10, 428–433 (2009). https://doi.org/10.1007/s11934-009-0068-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11934-009-0068-x

Keywords

  • Caffeine
  • Urinary Incontinence
  • Chronic Fatigue Syndrome
  • Overactive Bladder
  • Tolterodine